What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Malaria
- Gene
Ric N. Price mainly focuses on Malaria, Plasmodium falciparum, Plasmodium vivax, Immunology and Artesunate.
His Malaria research is multidisciplinary, incorporating elements of Internal medicine, Surgery and Drug resistance.
His study in Plasmodium falciparum is interdisciplinary in nature, drawing from both Quinine, Multiple drug resistance, Pharmacology and Virology.
He has researched Plasmodium vivax in several fields, including Epidemiology, Chloroquine, Antimalarial Agent, Primaquine and Global health.
His Immunology research includes elements of Endothelium and Lung injury.
The study incorporates disciplines such as Mefloquine and Piperaquine in addition to Artesunate.
His most cited work include:
- Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. (671 citations)
- Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. (671 citations)
- Vivax Malaria: Neglected and Not Benign (665 citations)
What are the main themes of his work throughout his whole career to date?
Ric N. Price spends much of his time researching Malaria, Plasmodium vivax, Plasmodium falciparum, Internal medicine and Immunology.
He studies Parasitemia, a branch of Malaria.
His Plasmodium vivax study combines topics in areas such as Epidemiology, Chloroquine, Primaquine, Plasmodium and Piperaquine.
His work carried out in the field of Plasmodium falciparum brings together such families of science as Drug resistance, Pharmacology and Virology.
His research integrates issues of Gastroenterology and Dihydroartemisinin/piperaquine in his study of Internal medicine.
His studies in Immunology integrate themes in fields like Endothelium and Asymptomatic.
He most often published in these fields:
- Malaria (122.83%)
- Plasmodium vivax (90.09%)
- Plasmodium falciparum (78.94%)
What were the highlights of his more recent work (between 2017-2021)?
- Malaria (122.83%)
- Plasmodium vivax (90.09%)
- Plasmodium falciparum (78.94%)
In recent papers he was focusing on the following fields of study:
Ric N. Price focuses on Malaria, Plasmodium vivax, Plasmodium falciparum, Internal medicine and Primaquine.
His Malaria research includes themes of Hazard ratio and Virology.
His Plasmodium vivax research incorporates themes from Epidemiology, Genotyping, Incidence and Pediatrics.
The Plasmodium falciparum study which covers Drug resistance that intersects with Mutation and Lineage.
His biological study spans a wide range of topics, including Gastroenterology, Parasitemia and Artesunate.
His Artemisinin study combines topics in areas such as Mefloquine and Pharmacology, Dosing.
Between 2017 and 2021, his most popular works were:
- Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study (94 citations)
- Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study (94 citations)
- UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. (76 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Malaria
- Gene
His primary scientific interests are in Malaria, Plasmodium vivax, Plasmodium falciparum, Primaquine and Internal medicine.
He specializes in Malaria, namely Plasmodium.
His Plasmodium vivax research focuses on Incidence and how it connects with Transmission and Virology.
His study in Plasmodium falciparum is interdisciplinary in nature, drawing from both Pharmacology and Drug discovery.
His Internal medicine research includes elements of Piperaquine, Dihydroartemisinin/piperaquine and Haemolysis.
As part of one scientific family, Ric N. Price deals mainly with the area of Dihydroartemisinin/piperaquine, narrowing it down to issues related to the Chloroquine, and often Artesunate.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
